Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
Cibus (NASDAQ: CBUS) has affirmed its collaboration with RTDC and Albaugh to commercialize its Clethodim-tolerant HT-3 rice trait, a gene-edited weed management solution for U.S. rice farmers. The partnership combines Cibus' gene editing expertise with Albaugh's crop protection and market development capabilities.
The company has secured four seed partners for this trait - two in the United States and two in South America - and is in discussions with major rice seed companies in Asia. The HT-3 trait represents a breakthrough in herbicide tolerance technology and is expected to be the first of several stacked weed management traits in rice from Cibus.
Cibus (NASDAQ: CBUS) ha confermato la sua collaborazione con RTDC e Albaugh per commercializzare il suo tratto HT-3, tollerante al Clethodim, una soluzione di gestione delle erbacce per i coltivatori di riso degli Stati Uniti. La partnership unisce l'expertise di Cibus nella modifica genetica con le capacità di protezione delle colture e sviluppo del mercato di Albaugh.
L'azienda ha assicurato quattro partner sementieri per questo tratto - due negli Stati Uniti e due in Sud America - ed è in trattative con importanti aziende sementiere di riso in Asia. Il tratto HT-3 rappresenta una rivoluzione nella tecnologia di tolleranza agli erbicidi e si prevede che sarà il primo di diversi tratti di gestione delle erbacce a strati nel riso da Cibus.
Cibus (NASDAQ: CBUS) ha afirmado su colaboración con RTDC y Albaugh para comercializar su rasgo HT-3, tolerante a Clethodim, una solución de manejo de malezas para los productores de arroz en los Estados Unidos. La asociación combina la experiencia en edición genética de Cibus con las capacidades de protección de cultivos y desarrollo de mercado de Albaugh.
La empresa ha asegurado cuatro socios de semillas para este rasgo - dos en Estados Unidos y dos en Sudamérica - y está en conversaciones con importantes empresas de semillas de arroz en Asia. El rasgo HT-3 representa un avance en la tecnología de tolerancia a herbicidas y se espera que sea el primero de varios rasgos de manejo de malezas apilados en arroz por parte de Cibus.
Cibus (NASDAQ: CBUS)는 RTDC 및 Albaugh와 협력하여 미국 쌀 농민을 위한 유전자 편집 잡초 관리 솔루션인 Clathodim 내성을 가진 HT-3 쌀 특성을 상업화할 것이라고 발표했습니다. 이 파트너십은 Cibus의 유전자 편집 전문성과 Albaugh의 작물 보호 및 시장 개발 능력을 결합합니다.
회사는 이 특성에 대해 네 개의 종자 파트너를 확보했으며 - 미국에서 두 곳, 남미에서 두 곳 - 아시아의 주요 쌀 종자 회사와 논의 중입니다. HT-3 특성은 제초제 내성 기술의 혁신을 의미하며, Cibus에서 쌀에 여러 개의 복합 잡초 관리 특성을 제공하는 첫 번째 특성이 될 것으로 예상됩니다.
Cibus (NASDAQ: CBUS) a confirmé sa collaboration avec RTDC et Albaugh pour commercialiser son trait HT-3 tolérant au Clethodim, une solution de gestion des mauvaises herbes pour les riziculteurs américains. Ce partenariat combine l'expertise en édition génétique de Cibus avec les capacités de protection des cultures et de développement du marché d'Albaugh.
L'entreprise a sécurisé quatre partenaires semenciers pour ce trait - deux aux États-Unis et deux en Amérique du Sud - et est en discussion avec des entreprises de semences de riz majeures en Asie. Le trait HT-3 représente une avancée dans la technologie de tolérance aux herbicides et devrait être le premier de plusieurs traits de gestion des mauvaises herbes empilés dans le riz de Cibus.
Cibus (NASDAQ: CBUS) hat seine Zusammenarbeit mit RTDC und Albaugh zur Vermarktung seines Clethodim-toleranten HT-3-Reismerkmals, einer gen-editierenden Unkrautmanagementlösung für US-Reisbauern, bestätigt. Die Partnerschaft vereint die Expertise von Cibus in der Genbearbeitung mit Albaughs Fähigkeiten im Bereich Pflanzenschutz und Marktentwicklung.
Das Unternehmen hat vier Saatgutpartner für dieses Merkmal gesichert - zwei in den Vereinigten Staaten und zwei in Südamerika - und verhandelt mit führenden Reis-Saatgutunternehmen in Asien. Das HT-3-Merkmal stellt einen Durchbruch in der Technologie zur Unkrautresistenz dar und wird voraussichtlich das erste von mehreren gestapelten Unkrautmanagementmerkmalen im Reis von Cibus sein.
- Strategic partnership with Albaugh and RTDC enhances commercialization capabilities
- Secured four seed partners across U.S. and South America markets
- Potential expansion into Asian markets through ongoing discussions
- Development of stackable traits indicates future growth potential
- No immediate revenue generation mentioned
- Timeline for market launch not specified
- Regulatory approvals status not addressed
Insights
This partnership represents a significant strategic advancement in Cibus' commercialization efforts for their gene-edited herbicide-tolerant rice trait. The collaboration with Albaugh, a major player in crop protection and RTDC adds important expertise in herbicide registration and market development. The HT-3 trait technology addresses a critical market need in the
The company's expanding partnerships with four seed companies across multiple continents and ongoing discussions in Asia indicate strong market potential. The development of stacked weed management traits suggests a comprehensive product pipeline that could generate substantial recurring royalty revenues. This positions Cibus to capture significant market share in the herbicide-tolerant rice segment, particularly as the first-mover with this specific solution.
The strategic value of this collaboration lies in its comprehensive approach to commercialization. By securing both seed partners and herbicide expertise, Cibus is building a complete ecosystem for their product launch. The global rice market presents a substantial opportunity, with the U.S. market serving as an initial launch point before potential expansion into larger Asian markets. The stacking capability of their traits creates multiple revenue opportunities and potential pricing power.
The partnership with established players like Albaugh significantly de-risks the commercialization process and could accelerate market adoption. This development is particularly noteworthy for a company with a
Cibus’ Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in the U.S.
Cibus and its partners Albaugh and RTDC Continue Their Research and Development Collaboration to Enable Commercialization of Cibus’ Clethodim-Tolerant HT-3 Rice Trait
SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties announced an agreement affirming its collaboration with RTDC Corporation Limited and Albaugh LLC to provide Clethodim as part of Cibus’ weed management solution for U.S. rice farmers using Cibus’ HT-3 trait. This continued collaboration with Albaugh, a global leader in crop protection, lends complementary market development and herbicide registration expertise and experience to Cibus’ gene editing trait expertise. The collaboration is instrumental to Cibus’ herbicide resistant rice trait commercialization efforts as Cibus also continues its work with its U.S. rice seed customers to bring its Clethodim-tolerant trait to market. These seed and crop protection collaborations are expected to bring together the rice production knowledge and expertise needed to successfully deliver improved rice weed management solutions for U.S. rice growers.
Weed pressure impacts crop yield and quality. Herbicide tolerance traits are an important tool for growers to manage weeds and are a key product area of the multi-billion-dollar trait industry globally. Cibus’ Clethodim tolerant HT-3 trait is an important breakthrough for a novel weed management solution for rice farmers and is one of the two herbicide tolerant traits in rice developed by Cibus that are expected to give rice growers excellent new solutions to manage weeds. It expected to be the first of several stacked weed management traits in rice from Cibus. Cibus currently has four seed partners for this trait: two in the United States and two in South America and is in discussion with other major rice seed companies to advance HT-3 rice in Asia.
Chad W. Shelton, Albaugh’s Group Director for Herbicide Tolerant Crops, stated, “This strategic collaboration and innovative technology has a strong potential to help rice growers in the U.S. and strategic rice markets around the globe keep pace with the most up-to-date herbicide-tolerant crop technologies for assuring high yields and crop quality. Albaugh is excited to be a part of this strategic partnership to develop for rice growers a cropping system powered by the HT-3 trait to help create and deliver performance value.”
Calvin Lu, Vice General Manager of RTDC, commented, “This technology combines the best of Gene Editing technologies from Cibus and superior herbicides provided by Albaugh to help rice growers to increase weed management options with better efficacy against difficult weeds. We are proud to be part of this project combining strengths of three companies in terms of technologies and geographies.”
Norm Sissons, Senior Vice President of Seeds and Traits at Cibus, added, “This partnership with Albaugh completes a critical component of our commercial strategy to bring our Clethodim-tolerant HT-3 trait to market. As we further our collaboration with Albaugh and its professional team of experts with a strong commercial focus enabling getting products to market, we see a promising path to bring Cibus’ novel weed management solution to Rice growers.”
About Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “anticipates,” “believes,” “continue,” “estimates,” “expects,” “intends,” “may,” “might,” “plans,” “predicts,” “projects,” “should,” “targets,” “will,” or the negative of these terms and other similar terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated closing of the offering and the expected use of the proceeds from the offering. Completion of the offering is subject to numerous factors, many of which are beyond Cibus’ control, including, without limitation, market conditions, failure to satisfy customary closing conditions and the risk factors and other matters set forth in the prospectus supplement and accompanying prospectus included in the registration statement and the documents incorporated by reference therein. You are cautioned not to place undue reliance on any forward-looking statements made by Cibus’ management, which are based only on information currently available to it when, and speak only as of the date, such statement is made. Cibus does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by law.
CIBUS CONTACTS:
INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
MEDIA RELATIONS
Colin Sanford
colin@bioscribe.com
203-918-4347
FAQ
What is the significance of Cibus' HT-3 trait collaboration with Albaugh and RTDC?
How many seed partners does Cibus (CBUS) currently have for the HT-3 trait?
What markets is Cibus (CBUS) targeting for its HT-3 rice trait?
What is the commercial potential of Cibus' HT-3 trait in the rice industry?
